Scarica l'app Stockscreener
5.09
2.21%
0.11
Dopo l'orario di chiusura:
5.09
Precedente Chiudi:
$4.98
Aprire:
$4.99
Volume 24 ore:
735.48K
Relative Volume:
1.61
Capitalizzazione di mercato:
$342.01M
Reddito:
-
Utile/perdita netta:
$-64.20M
Rapporto P/E:
-3.0118
EPS:
-1.69
Flusso di cassa netto:
$57,000
1 W Prestazione:
-33.29%
1M Prestazione:
-27.18%
6M Prestazione:
+85.77%
1 anno Prestazione:
+93.54%
Intervallo 1D:
$4.92
$5.23
Intervallo di 1 settimana:
$4.7521
$8.15
Portata 52W:
$2.35
$11.55
Eliem Therapeutics Inc Stock (ELYM) Company Profile
Nome
Eliem Therapeutics Inc
Settore
Industria
Telefono
877-354-3689
Indirizzo
2801 CENTERVILLE ROAD 1ST FLOOR, WILMINGTON
Eliem Therapeutics Inc Borsa (ELYM) Ultime notizie
Eliem Therapeutics Inc (ELYM) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Ratio Analysis: Unpacking Eliem Therapeutics Inc (ELYM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Eliem Therapeutics, Inc. (NASDAQ:ELYM) Shares Sold by Driehaus Capital Management LLC - MarketBeat
Selling Eliem Therapeutics Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Simply Wall St
Private equity firms who have a significant stake must be disappointed along with institutions after Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) market cap dropped by US$231m - Yahoo Finance
Eliem Therapeutics Inc (ELYM) can make a big difference with a little luck - SETE News
Eliem Therapeutics Inc (ELYM) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Affinity Asset Advisors LLC Takes $11.88 Million Position in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat
Trading (ELYM) With Integrated Risk Controls - Stock Traders Daily
500,000 Shares in Eliem Therapeutics, Inc. (NASDAQ:ELYM) Acquired by Ally Bridge Group NY LLC - MarketBeat
Eliem Therapeutics: Recent Strategic Pipeline Restructuring (NASDAQ:ELYM) - Seeking Alpha
Closing Figures: Eliem Therapeutics Inc (ELYM)’s Positive Finish at 8.43, Up 1.81 - The Dwinnex
Eliem Therapeutics Inc (ELYM)’s stock price in review: A technical analysis - US Post News
Eliem therapeutics executive sells over $9,000 in company stock - Investing.com
Eliem therapeutics executive sells over $9,000 in company stock - Investing.com India
Eliem therapeutics executive sells over $9,000 in company stock By Investing.com - Investing.com Canada
(ELYM) Trading Signals - Stock Traders Daily
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - GlobeNewswire
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - StockTitan
Eliem Therapeutics (NASDAQ:ELYM) Trading Up 4.6% - MarketBeat
Eliem Therapeutics Inc [ELYM] Investment Appeal on the Rise - Knox Daily
ELYM’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
A Guide To The Risks Of Investing In Eliem Therapeutics Inc (ELYM) - Knox Daily
Eliem Therapeutics appoints Kaplan as COO; Rampal as SVP, Clinical Development - MSN
Eliem Therapeutics announces executive changes, refocuses on autoimmune diseases - Investing.com India
Eliem Therapeutics announces executive changes, refocuses on autoimmune diseases - Investing.com
Eliem Therapeutics: Executive Changes Amid Strategic Shift - TipRanks
Eliem Therapeutics expands executive team with new COO and SVP - Investing.com
Eliem Therapeutics appoints new COO Brett Kaplan - Investing.com
Eliem Therapeutics expands executive team with new COO and SVP - Investing.com India
Eliem Therapeutics appoints new COO Brett Kaplan By Investing.com - Investing.com UK
Eliem Therapeutics Names Brett Kaplan as New COO - TipRanks
Eliem Therapeutics Announces Additions to its Leadership Team - GlobeNewswire
Eliem Therapeutics Announces Additions to its Leadership Team - GlobeNewswire Inc.
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q2 2024 - MSN
(ELYM) Long Term Investment Analysis - Stock Traders Daily
Eliem Therapeutics, Inc. (NASDAQ:ELYM) Short Interest Up 34.0% in July - Defense World
Eliem Therapeutics, Inc. (NASDAQ:ELYM) Short Interest Up 34.0% in July - MarketBeat
Analyzing Eliem Therapeutics Inc (ELYM) After Recent Trading Activity - Knox Daily
Eliem Therapeutics Reports Second Quarter Financial Results - ForexTV.com
Eliem Therapeutics Reports Second Quarter Financial Results - GlobeNewswire
Eliem Therapeutics Reports Second Quarter Financial Results - Yahoo Finance
Sciatica Treatment Industry is Expected to Reach Rapid Growth - openPR
ELYM’s 2023 Market Dance: Up 124.07% – Time to Invest? - The InvestChronicle
Daily Progress: Eliem Therapeutics Inc (ELYM) Drop -15.50, Closing at 6.05 - The Dwinnex
Recent Insider Activity Could Benefit Eliem Therapeutics Inc (ELYM) - Knox Daily
How To Trade (ELYM) - Stock Traders Daily
Where are the Opportunities in (ELYM) - Stock Traders Daily
Eliem Therapeutics, Inc. (NASDAQ:ELYM) Sees Significant Growth in Short Interest - MarketBeat
Eliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Valerie Morisset Sells 60,201 Shares - Defense World
Eliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Valerie Morisset Sells 69,005 Shares - Defense World
Eliem Therapeutics Inc Azioni (ELYM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
4.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):